cAmp modulates exocytotic kinetics and increases quantal size in chromaffin cells

Mol Pharmacol. 2001 Sep;60(3):514-20.

Abstract

The role of cAMP/cAMP-dependent protein kinase (PKA) on the late phase of exocytosis has been studied by amperometry on Ba(2+)-stimulated single bovine chromaffin cells. Forskolin (FSK) increases the intracellular cAMP levels in a concentration-dependent manner. Forskolin (100 nM) does not increase the number of exocytotic events, although it significantly increases the net granule content of catecholamines (CA), which is accompanied by a slowing of the process of degranulation. These effects are reversible, occur within 15 to 60 s, and are not due to newly synthesized CA. Isoprenaline, pituitary adenylate cyclase-activating polypeptide-38 or dB-cAMP reproduce FSK effects as does cholera toxin. The inhibition of phosphodiesterases with 3-isobutyl-1-methylxanthine mimics and potentiates the effect of FSK and isoprenaline. Rolipram and okadaic acid also produce a drastic increase in net granule content of CA, whereas H-89 attenuates the FSK response. These data indicate that cyclic AMP/PKA might favor the granule aggregation before its fusion with cell membrane and slow the late step of the exocytotic process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Cells, Cultured
  • Chromaffin Cells / drug effects*
  • Chromaffin Cells / physiology
  • Chromaffin Granules / drug effects
  • Chromaffin Granules / physiology
  • Colforsin / pharmacology
  • Cyclic AMP / chemistry
  • Cyclic AMP / pharmacology*
  • Exocytosis / drug effects*
  • Isoproterenol / pharmacology
  • Kinetics
  • Molecular Mimicry
  • Neuropeptides / pharmacology
  • Nitric Oxide / metabolism
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Synapses / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Neuropeptides
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Vasodilator Agents
  • Colforsin
  • Nitric Oxide
  • Cyclic AMP
  • Isoproterenol